drugset
Drugs / Nifuroxazide
last change Jul 2025 re-read 2 minutes ago

Nifuroxazide

also known as Ercefuryl 200 · Nifuroxazida · NSC-759261 · RC-27109 · SJ000287313

Small molecule

Developed for
hepatic encephalopathy · inflammatory bowel disease
Investigated by
Cairo University

Trials 1 · a red edge is where a trial was stopped

today NCT05754996 · Ph 3
202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT05754996 Mar 2023 → Jul 2025 hepatic encephalopathy Cairo University Completed No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2/3 NCT05988528 Comparator Aug 2023 → Feb 2025 inflammatory bowel disease Mostafa Bahaa Completed No outcome recorded

Evidence & citations 8 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as Nifuroxazide ClinicalTrials.gov intervention name — accepted as the source's own label NCT05754996 ↗
1

NCT05988528 ↗
Known as Ercefuryl 200 ChEMBL registry synonym — accepted as the source's own label CHEMBL244888 ↗
Known as Nifuroxazida ChEMBL registry synonym — accepted as the source's own label CHEMBL244888 ↗
Known as NSC-759261 ChEMBL registry synonym — accepted as the source's own label CHEMBL244888 ↗
Known as RC-27109 ChEMBL registry synonym — accepted as the source's own label CHEMBL244888 ↗
Known as SJ000287313 ChEMBL registry synonym — accepted as the source's own label CHEMBL244888 ↗
Modality Small molecule — CHEMBL244888 ↗
Route Oral “Nifuroxazide is an oral broad-spectrum nitrofuran antibiotic” NCT05754996 ↗